NovaBridge Biosciences (NBP) Other Accumulated Expenses (2022 - 2026)

NovaBridge Biosciences (NBP) has reported Other Accumulated Expenses for 4 consecutive years, with $9.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 8560.38% year-over-year to $9.2 million; the TTM figure through Dec 2025 stood at $9.2 million (up 8560.38% YoY), while the FY2025 annual figure was $9.2 million, up 8560.38% from the prior year.
• Other Accumulated Expenses advanced to $9.2 million in Q4 2025 per NBP's latest filing, from $2.3 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $9.2 million in Q4 2025 and bottomed at $106000.0 in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $4.6 million across 4 years, with a median of $3.6 million in 2023.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses tumbled 97.82% — and 2025, when it jumped 8560.38%.
• NovaBridge Biosciences' Other Accumulated Expenses stood at $9.1 million in 2022, then plunged by 46.54% to $4.9 million in 2023, then sank by 97.82% to $106000.0 in 2024, then surged by 8560.38% to $9.2 million in 2025.
• Business Quant data shows NBP's Other Accumulated Expenses at $9.2 million in Q4 2025, $2.3 million in Q3 2025, and $1.9 million in Q2 2025.